跳至主要内容
临床试验/IRCT20211213053377N1
IRCT20211213053377N1招募中3 期

The investigating of radioprotective effect of metformin against radiotherapy-induced urinary, gastrointestinal complications and genotoxicity in prostate cancer patients

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Male

入选标准

  • Patients localized prostate adenocarcinoma cancer
  • Prescribe of definitive or postoperative external beam radiotherapy
  • Consent to participate in the study

排除标准

  • Patients with metastatic prostate cancer
  • Previous history of radiation or chemotherapy
  • Renal and hepatic dysfunction
  • Patients with cardiovascular failure
  • Patients with severe respiratory problems (such as obstructive pulmonary disease, severe asthma)
  • Patients with blood problems (such as anemia, vitamin B12 deficiency)
  • Diabetic patients
  • Smoking patients

研究者

相似试验